BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34194489)

  • 1. Epigenetic Modulation of Microglia Function and Phenotypes in Neurodegenerative Diseases.
    Wang L; Yu CC; Liu XY; Deng XN; Tian Q; Du YJ
    Neural Plast; 2021; 2021():9912686. PubMed ID: 34194489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review.
    Wen KX; Miliç J; El-Khodor B; Dhana K; Nano J; Pulido T; Kraja B; Zaciragic A; Bramer WM; Troup J; Chowdhury R; Ikram MA; Dehghan A; Muka T; Franco OH
    PLoS One; 2016; 11(12):e0167201. PubMed ID: 27973581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heterogeneity of microglial activation and its epigenetic and non-coding RNA regulations in the immunopathogenesis of neurodegenerative diseases.
    Li C; Ren J; Zhang M; Wang H; Yi F; Wu J; Tang Y
    Cell Mol Life Sci; 2022 Sep; 79(10):511. PubMed ID: 36066650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rps27a might act as a controller of microglia activation in triggering neurodegenerative diseases.
    Khayer N; Mirzaie M; Marashi SA; Jalessi M
    PLoS One; 2020; 15(9):e0239219. PubMed ID: 32941527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration.
    Neal M; Richardson JR
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):432-443. PubMed ID: 29113750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy in Neuroinflammation: A Focus on Epigenetic Regulation.
    Chen Y; Chen J; Xing Z; Peng C; Li D
    Aging Dis; 2024 Apr; 15(2):739-754. PubMed ID: 37548945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of genetics and gender specific differences in neurodegenerative disorders: Insights from molecular and immune landscape.
    Hosseinzadeh S; Afshari S; Molaei S; Rezaei N; Dadkhah M
    J Neuroimmunol; 2023 Nov; 384():578206. PubMed ID: 37813041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards PET imaging of the dynamic phenotypes of microglia.
    Beaino W; Janssen B; Vugts DJ; de Vries HE; Windhorst AD
    Clin Exp Immunol; 2021 Dec; 206(3):282-300. PubMed ID: 34331705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic programming of neurodegenerative diseases by an adverse environment.
    Babenko O; Kovalchuk I; Metz GA
    Brain Res; 2012 Mar; 1444():96-111. PubMed ID: 22330722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Epigenetics in Neuroinflammatory-Driven Diseases.
    Giallongo S; Longhitano L; Denaro S; D'Aprile S; Torrisi F; La Spina E; Giallongo C; Mannino G; Lo Furno D; Zappalà A; Giuffrida R; Parenti R; Li Volti G; Tibullo D; Vicario N
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy.
    Gangisetty O; Murugan S
    Adv Neurobiol; 2016; 12():1-25. PubMed ID: 27651245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Nutrition, Lifestyle, and Neurodegenerative Disease: Lessons from
    Barati S; Fabrizio C; Strafella C; Cascella R; Caputo V; Megalizzi D; Peconi C; Mela J; Colantoni L; Caltagirone C; Termine A; Giardina E
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Regulation in Neurodegenerative Diseases.
    Berson A; Nativio R; Berger SL; Bonini NM
    Trends Neurosci; 2018 Sep; 41(9):587-598. PubMed ID: 29885742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases.
    Nainu F; Mamada SS; Harapan H; Emran TB
    Adv Exp Med Biol; 2023; 1411():39-70. PubMed ID: 36949305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.
    Tang Y; Le W
    Mol Neurobiol; 2016 Mar; 53(2):1181-1194. PubMed ID: 25598354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands.
    Bogár F; Fülöp L; Penke B
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions.
    Prasanth MI; Sivamaruthi BS; Cheong CSY; Verma K; Tencomnao T; Brimson JM; Prasansuklab A
    Antioxidants (Basel); 2024 May; 13(5):. PubMed ID: 38790711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Basis of Lead-Induced Neurological Disorders.
    Wang T; Zhang J; Xu Y
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32645824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of histone post-translational modifications in neurodegenerative diseases.
    Cobos SN; Bennett SA; Torrente MP
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):1982-1991. PubMed ID: 30352259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.